Zeta Thyroglobulin Antibody Cocktail. Zeta’s recombinant mouse antibody cocktail of two defined monoclonals recognizes Thyroglobulin, a marker useful in positive identification of thyroid carcinomas of the papillary and follicular types. Demonstration of Thyroglobulin in a metastatic lesion establishes the thyroid origin of the tumor. Adenocarcinomas of non-thyroidal origin are not reactive for Thyroglobulin. Zeta’s Clone 2H11+6E1 antibody cocktail is designed for sensitive detection of Thyroglobulin. Zeta’s Thyroglobulin antibody stains Thyroglobulin in follicular epithelial cells as well as colloid tissue.
Zeta Corporation is a leader in recombinant monoclonal IVD antibodies for immunohistochemistry (IHC) offering 400+ tumor and tissue specific relevant products developed by a pathologist for pathologists. Visit Precision Recombinant Antibodies – IVD Antibodies – About Zeta Corporation (zeta-corp.com) to learn more about Zeta Corporation.